Skip to Content
scroll

EchoIQ Ltd (EIQ)

EIQ $0.80

20 MINUTE DELAYED

14 DAYS FREE ACCESS

Join Market Matters and get full access
to all our Opinion + Action

LEARN MORE

EIQ $0.80

20 MINUTE DELAYED

TODAY

11.11 %

1 YEAR RETURN

0.00%

VOLUME

5,460,979

DIV YIELD

0%

PE RATIO

0.00

52 WEEK RANGE

0.17

0.76

ANALYSIS

i

SHARE PRICE ACTIVITY
Last (Price)

0.80

Change

0.08 (11.11)

Bid / Ask

0.79 - 0.80

Volume

5,460,979

Turnover

4,249,870

Open

0.73

Day Range

0.72 - 0.81

VWAP

0.78

Prev Close

0.72

Last Trade

25/03 4:11pm (AEST)

i

KEY INFORMATION
Sector

Shares Issued

NTA/Share

0.00

Last Dividend

0.00

Dividend Ex Date

0

Dividend Pay Date

0

i

BROKER CALLS

current

Mean

0.00

Target Price

0.00

i

CURRENT ()
Revenue

EBITDA

Profit

Earnings Per Share (EPS)

0

Dividend Per Share (DPS)

0

Yield %

0.00

Market Cap

0

Price to Earnings Ratio (P/E)

0

i

TARGET PRICE FORECAST

i

ESTIMATES ()
Revenue

0.00

EBITDA

0.00

Profit

0.00

Earnings Per Share (EPS)

0.00

Dividend Per Share (DPS)

0.00

i

BROKER CONSENSUS RECOMMENDATION

BUY

SELL

Target Price

0.00

Lt Growth Rate

0.00

Recommendation ()

0.00
image description

Business Summary

EchoIQ Limited (ECHOiQ), formerly Houston We Have Limited, is an Australia-based health and medical technology company. The Company is engaged in the product development, marketing and commercialization of software products and services. It provides cardiac diagnostics technology. ECHOiQ’s technology uses artificial intelligence (ai) assisted diagnostics to deliver real-world health solutions. Its screening program uses an AI backed system and access to cardiac big data that identifies patients at risk from aortic stenosis and other forms of structural heart disease. Its technology addresses aortic stenosis, heart failure, and mitral and tricuspid regurgitation. The Company also offers Prometheus that help health funds and insurers understand their providers. It identifies providers showing signs or early indicators of unusual behaviors that might be related to fraud, claiming errors, or other patterns worthy of further investigation.

image description

Relevant suggested news and content from the site

image description

Only available to Members

Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required
For membership options and pricing. Click here
Back to top